FDA advisers to weigh composition of COVID vaccines for 2026-2027
May 28 - The U.S. FDA's advisory panel will meet and then vote on Thursday on whether COVID-19 vaccines for the 2026-2027 immunization campaign should target the dominant XFG variant, after staff members raised concerns about limited data on currently circulating strains. Read more at straitstimes.com. Read more at straitstimes.com.
28 May 10:09 · The Straits Times